Potential for KY19382 on longitudinal growth (high iq debunkers gtfih)

birthdefect

birthdefect

Kraken
Joined
Dec 24, 2025
Posts
3,400
Reputation
3,742
disclaimer: this is my thread from .gg
again just gonna be a quick thread like the last one on combining ghrfs + gh

ky19382 is a small molecule indirubin analogue which acts primarily as an inhibitor of the protein-protein interaction between CXXC5 and Dishevelled (dvl), while simultaneously acting as a Glycogen Synthase Kinase 3 Beta(gsk3b) inhibitor. Through these actions, it acts as a potent canonical Wnt/Beta catenin upregulator. Originally used to treat alopecia through upregulation of the Wnt/B catenin pathway, it was found to also promote wound healing, and most importantly longitudinal growth in adolescent mice.

Hair growth: ky19382 was shown to be more effective than minoxidil in rats in one study, and was able to promote de novo follicle formation, as in the growth of completely new hair follicles in adult tissue, thought to have been impossible until the discovery of this and other Wnt and HH modulators/upregulators.

Wound Healing: ky19382 accelerates wound healing by around 30%-50%, and was significantly faster than using endothelial growth factor (EGF) and PTD-DBM, which is a peptide that targets the same pathway as ky19382 itself. PTD-DBM is most likely inferior to ky19382 due to not affecting gsk3b, a factor which when inhibited, promotes the accumulation of nuclear beta catenin, which is beneficial for all of ky19382's desired effects.

Longitudinal growth:
This is the real important part on why ky19382 is such a mogger compound.
I'm sure that basically everyone on here knows that estrogen fuses the plates. It does this through both genomic and non genomic signalling pathways, which I'm not going to get deep into. When estrogen binds to the estrogen receptor alpha (ErA), it dimerises into hetero or homo dimers and moves within the nucleus of the cell. These dimers bind to estrogen response elements (ERE) in the cxxc5 promoter region of the dna, leading to increased cxxc5 expression which acts as the direct tool to upregulate growth plate fusion. CXXC5 causes a decrease in nuclear beta catenin levels, which are necessary to promote proliferative genes such as Sox9. We know a lack of CXXC5 can prevent estrogen from inducing senescence, because in mice models where the gene of CXXC5 is knocked out, the plates can't close even in high estrogen environments.

From this, I'm sure you've gathered that CXXC5 inhibition is very downstream and likely smarter compared to the relatively caveman-brained method of just inhibiting aromatase to slow bone age. But, does this mean its enough?

Is aromatase inhibition still needed?

From the studies with CXXC5 knockout models, we know that even if CXXC5 is missing and the plates cant fuse, estrogen genomic signalling still occurs as the receptor can bind to other genes. This means that even though your chondrocytes will keep proliferating and hypertrophying, your chondrocytes will still "age", in the sense that as they continue to multiply, they will retain the genomic changes made by estrogen, maturing and dying faster than they would have otherwise. Using ky19382 would likely allow for estrogen levels to be higher than actually needed to delay fusion, but you might still need to use low dose aromatase inhibitors (i recommend arimidex). I genuinely believe that aromatase inhibition combined with cxxc5 - dvl inhibition could potentially add 3+ years of active growth plate chondrocyte proliferation, hypertrophy, and thus growth.

Can more be done?

I'm sure most of you have heard of HDACi to promote longitudinal growth, unfortunately the reasoning behind it is pretty shit and pan-hdaci such as vorinostat are known to have a detrimental impact on growth. A lot of hdacs are necessary for longitudinal growth to occur, and one of high interest is HDAC4. HDAC4 is a crucial downstream factor to prevent chondrocytes from beginning to hypertrophy. Theoretically, if HDAC4 was upregulated, aromatase was inhibited, and cxxc5 - dvl interaction was inhibited, the growth plate may never fuse, allowing us to use androgens and hgh for pretty much as long as we need. I'm not going to get into how HDAC4 could be increased in the growth plate (likely gonna gatekeep further information on exact compounds needed), but the potential is there.

How would KY19382 actually be used?

A benefit of using small molecules over most other compounds is oral bioavailability, which ky19382 favourably exhibits. From some studies ive read (and just asking google's ai :forcedsmile:) the best easily available solvent for it is peg400 at around a 60%-80% mix with water (probably distilled or purified or whatever). Buying it from a mainstream source is genuinely expensive as fuck, on medchem express 100mg costs like 2k usd. Comparatively, from my source ky19382 costs around the same but for 10 grams, which lasts way way longer. To convert rat oral dosing to human dosing you have to determine human equivalent dose, which im not fucked explaining. Just ask ai to do it
sorry for the giga low effort thread i wasnt bothered finding pictures, if i got anything wrong please correct me cus this is all from memory

tagging high iq niggas
@Zagro @Stacyslayerᛉ @Sachlichkeit
 
  • +1
Reactions: seigi, Boosie’s_Build, thuuk and 5 others
shits gonna get ignored like the last thread :feelsrope:
 
  • +1
Reactions: Boosie’s_Build, Stacyslayerᛉ, Orka and 1 other person
Not worth it
 
  • +1
Reactions: 100%nt, childishkillah, Micrognathic and 2 others
Just use AI + the price and efficiency ratio is bad
id imagine combining the 2 would be more effective than using just one. and its not that expensive if you can source it right, costs like a couple hundred for a years worth if you use it everyday and it increases chondrocyte proliferation while also delaying senescence
thank you for feedback bby :ogre:
 
  • +1
Reactions: Stacyslayerᛉ and Zagro
id imagine combining the 2 would be more effective than using just one. and its not that expensive if you can source it right, costs like a couple hundred for a years worth if you use it everyday and it increases chondrocyte proliferation while also delaying senescence
thank you for feedback bby :ogre:
I would need like 60mg daily for the translated human dose + considering the bioavailability changes in oral dosing, so even buying 1g for 200$ it lasts like 15 days
 
  • Hmm...
  • +1
Reactions: childishkillah and Micrognathic
bro what how big are you, how much do you weigh and how tall are you?
 
  • +1
Reactions: Stacyslayerᛉ
bro what how big are you, how much do you weigh and how tall are you?
66kg and you need to also consider that the oral bioavailability is like 10%-25% max
 
  • +1
Reactions: birthdefect, childishkillah, Stacyslayerᛉ and 1 other person
Yo, sorry I didn’t saw your last thread, was on vacation. Will read this thread later :feelsokman:
 
  • Love it
  • So Sad
Reactions: slaminnnn1 and birthdefect
66kg and you need to also consider that the oral bioavailability is like 10%-25% max
i guess ill be the labrat
im pretty sure that would be enough honestly, planning on taking it sublingually
 
  • +1
Reactions: Stacyslayerᛉ
disclaimer: this is my thread from .gg
again just gonna be a quick thread like the last one on combining ghrfs + gh

ky19382 is a small molecule indirubin analogue which acts primarily as an inhibitor of the protein-protein interaction between CXXC5 and Dishevelled (dvl), while simultaneously acting as a Glycogen Synthase Kinase 3 Beta(gsk3b) inhibitor. Through these actions, it acts as a potent canonical Wnt/Beta catenin upregulator. Originally used to treat alopecia through upregulation of the Wnt/B catenin pathway, it was found to also promote wound healing, and most importantly longitudinal growth in adolescent mice.

Hair growth: ky19382 was shown to be more effective than minoxidil in rats in one study, and was able to promote de novo follicle formation, as in the growth of completely new hair follicles in adult tissue, thought to have been impossible until the discovery of this and other Wnt and HH modulators/upregulators.

Wound Healing: ky19382 accelerates wound healing by around 30%-50%, and was significantly faster than using endothelial growth factor (EGF) and PTD-DBM, which is a peptide that targets the same pathway as ky19382 itself. PTD-DBM is most likely inferior to ky19382 due to not affecting gsk3b, a factor which when inhibited, promotes the accumulation of nuclear beta catenin, which is beneficial for all of ky19382's desired effects.

Longitudinal growth:
This is the real important part on why ky19382 is such a mogger compound.
I'm sure that basically everyone on here knows that estrogen fuses the plates. It does this through both genomic and non genomic signalling pathways, which I'm not going to get deep into. When estrogen binds to the estrogen receptor alpha (ErA), it dimerises into hetero or homo dimers and moves within the nucleus of the cell. These dimers bind to estrogen response elements (ERE) in the cxxc5 promoter region of the dna, leading to increased cxxc5 expression which acts as the direct tool to upregulate growth plate fusion. CXXC5 causes a decrease in nuclear beta catenin levels, which are necessary to promote proliferative genes such as Sox9. We know a lack of CXXC5 can prevent estrogen from inducing senescence, because in mice models where the gene of CXXC5 is knocked out, the plates can't close even in high estrogen environments.

From this, I'm sure you've gathered that CXXC5 inhibition is very downstream and likely smarter compared to the relatively caveman-brained method of just inhibiting aromatase to slow bone age. But, does this mean its enough?

Is aromatase inhibition still needed?

From the studies with CXXC5 knockout models, we know that even if CXXC5 is missing and the plates cant fuse, estrogen genomic signalling still occurs as the receptor can bind to other genes. This means that even though your chondrocytes will keep proliferating and hypertrophying, your chondrocytes will still "age", in the sense that as they continue to multiply, they will retain the genomic changes made by estrogen, maturing and dying faster than they would have otherwise. Using ky19382 would likely allow for estrogen levels to be higher than actually needed to delay fusion, but you might still need to use low dose aromatase inhibitors (i recommend arimidex). I genuinely believe that aromatase inhibition combined with cxxc5 - dvl inhibition could potentially add 3+ years of active growth plate chondrocyte proliferation, hypertrophy, and thus growth.

Can more be done?

I'm sure most of you have heard of HDACi to promote longitudinal growth, unfortunately the reasoning behind it is pretty shit and pan-hdaci such as vorinostat are known to have a detrimental impact on growth. A lot of hdacs are necessary for longitudinal growth to occur, and one of high interest is HDAC4. HDAC4 is a crucial downstream factor to prevent chondrocytes from beginning to hypertrophy. Theoretically, if HDAC4 was upregulated, aromatase was inhibited, and cxxc5 - dvl interaction was inhibited, the growth plate may never fuse, allowing us to use androgens and hgh for pretty much as long as we need. I'm not going to get into how HDAC4 could be increased in the growth plate (likely gonna gatekeep further information on exact compounds needed), but the potential is there.

How would KY19382 actually be used?

A benefit of using small molecules over most other compounds is oral bioavailability, which ky19382 favourably exhibits. From some studies ive read (and just asking google's ai :forcedsmile:) the best easily available solvent for it is peg400 at around a 60%-80% mix with water (probably distilled or purified or whatever). Buying it from a mainstream source is genuinely expensive as fuck, on medchem express 100mg costs like 2k usd. Comparatively, from my source ky19382 costs around the same but for 10 grams, which lasts way way longer. To convert rat oral dosing to human dosing you have to determine human equivalent dose, which im not fucked explaining. Just ask ai to do it
sorry for the giga low effort thread i wasnt bothered finding pictures, if i got anything wrong please correct me cus this is all from memory

tagging high iq niggas
@Zagro @Stacyslayerᛉ @Sachlichkeit
ya

but WNTB pathway activation via KY19382 at human adjusted doses low reward high risk. At adjusted doses the cancer risk is massive correct me if im wrong.

Between theory and practical application you want to steer clear of research chemicals and lean on FDA approved drugs if you actually intend on using these things. I have bottle of oral self compounded KY in fridge rn, grew my hair out nice, thats about it. dosages were v and adjusted from anecdotal account of old poster who (apparently,) injected it. also muscle soreness.

ROMO is only FDA approved WNTB cantenin modulator, and has little effect on plates

TGFB transforming growth factor beta is more important for bone growth than WNTB though there is no drug available

if u want real edge on .org "competition" find out what the medical standard for X or Y is and then use that, because billions of dollars and hours have been poured into things you are probably researching.

I could say deca is the best steroid for bones, but some oldhead probably 30 years ago said the same thing, ran the studies, wasted bunch of time and money only to find out that testosterone is better risk reward for X or Y reason.

If "pfizer" could make a better androgen than testosterone, patent it, then market it as "TRT" they would because they would make billions, but they haven't.

The osteoporotic drugs are,
Romosozumab
PTH analogs
Biphosphonates
 
  • +1
Reactions: Boosie’s_Build
ya

but WNTB pathway activation via KY19382 at human adjusted doses low reward high risk. At adjusted doses the cancer risk is massive correct me if im wrong.

Between theory and practical application you want to steer clear of research chemicals and lean on FDA approved drugs if you actually intend on using these things. I have bottle of oral self compounded KY in fridge rn, grew my hair out nice, thats about it. dosages were v and adjusted from anecdotal account of old poster who (apparently,) injected it. also muscle soreness.

ROMO is only FDA approved WNTB cantenin modulator, and has little effect on plates

TGFB transforming growth factor beta is more important for bone growth than WNTB though there is no drug available

if u want real edge on .org "competition" find out what the medical standard for X or Y is and then use that, because billions of dollars and hours have been poured into things you are probably researching.

I could say deca is the best steroid for bones, but some oldhead probably 30 years ago said the same thing, ran the studies, wasted bunch of time and money only to find out that testosterone is better risk reward for X or Y reason.

If "pfizer" could make a better androgen than testosterone, patent it, then market it as "TRT" they would because they would make billions, but they haven't.

The osteoporotic drugs are,
Romosozumab
PTH analogs
Biphosphonates
why focus on bone over chondrocytes for height? although pthrp analogues do have the potential to keep the chondrocytes younger

would cancer risk between gh and ky19382 be similar or nah? as far as i know ky19382 restores wnt signalling rather thsn just upregulating it, and in certain cancers its shown to actuslly downregulate wnt. from memory tho could be wrong
 
Last edited:
disclaimer: this is my thread from .gg
again just gonna be a quick thread like the last one on combining ghrfs + gh

ky19382 is a small molecule indirubin analogue which acts primarily as an inhibitor of the protein-protein interaction between CXXC5 and Dishevelled (dvl), while simultaneously acting as a Glycogen Synthase Kinase 3 Beta(gsk3b) inhibitor. Through these actions, it acts as a potent canonical Wnt/Beta catenin upregulator. Originally used to treat alopecia through upregulation of the Wnt/B catenin pathway, it was found to also promote wound healing, and most importantly longitudinal growth in adolescent mice.

Hair growth: ky19382 was shown to be more effective than minoxidil in rats in one study, and was able to promote de novo follicle formation, as in the growth of completely new hair follicles in adult tissue, thought to have been impossible until the discovery of this and other Wnt and HH modulators/upregulators.

Wound Healing: ky19382 accelerates wound healing by around 30%-50%, and was significantly faster than using endothelial growth factor (EGF) and PTD-DBM, which is a peptide that targets the same pathway as ky19382 itself. PTD-DBM is most likely inferior to ky19382 due to not affecting gsk3b, a factor which when inhibited, promotes the accumulation of nuclear beta catenin, which is beneficial for all of ky19382's desired effects.

Longitudinal growth:
This is the real important part on why ky19382 is such a mogger compound.
I'm sure that basically everyone on here knows that estrogen fuses the plates. It does this through both genomic and non genomic signalling pathways, which I'm not going to get deep into. When estrogen binds to the estrogen receptor alpha (ErA), it dimerises into hetero or homo dimers and moves within the nucleus of the cell. These dimers bind to estrogen response elements (ERE) in the cxxc5 promoter region of the dna, leading to increased cxxc5 expression which acts as the direct tool to upregulate growth plate fusion. CXXC5 causes a decrease in nuclear beta catenin levels, which are necessary to promote proliferative genes such as Sox9. We know a lack of CXXC5 can prevent estrogen from inducing senescence, because in mice models where the gene of CXXC5 is knocked out, the plates can't close even in high estrogen environments.

From this, I'm sure you've gathered that CXXC5 inhibition is very downstream and likely smarter compared to the relatively caveman-brained method of just inhibiting aromatase to slow bone age. But, does this mean its enough?

Is aromatase inhibition still needed?

From the studies with CXXC5 knockout models, we know that even if CXXC5 is missing and the plates cant fuse, estrogen genomic signalling still occurs as the receptor can bind to other genes. This means that even though your chondrocytes will keep proliferating and hypertrophying, your chondrocytes will still "age", in the sense that as they continue to multiply, they will retain the genomic changes made by estrogen, maturing and dying faster than they would have otherwise. Using ky19382 would likely allow for estrogen levels to be higher than actually needed to delay fusion, but you might still need to use low dose aromatase inhibitors (i recommend arimidex). I genuinely believe that aromatase inhibition combined with cxxc5 - dvl inhibition could potentially add 3+ years of active growth plate chondrocyte proliferation, hypertrophy, and thus growth.

Can more be done?

I'm sure most of you have heard of HDACi to promote longitudinal growth, unfortunately the reasoning behind it is pretty shit and pan-hdaci such as vorinostat are known to have a detrimental impact on growth. A lot of hdacs are necessary for longitudinal growth to occur, and one of high interest is HDAC4. HDAC4 is a crucial downstream factor to prevent chondrocytes from beginning to hypertrophy. Theoretically, if HDAC4 was upregulated, aromatase was inhibited, and cxxc5 - dvl interaction was inhibited, the growth plate may never fuse, allowing us to use androgens and hgh for pretty much as long as we need. I'm not going to get into how HDAC4 could be increased in the growth plate (likely gonna gatekeep further information on exact compounds needed), but the potential is there.

How would KY19382 actually be used?

A benefit of using small molecules over most other compounds is oral bioavailability, which ky19382 favourably exhibits. From some studies ive read (and just asking google's ai :forcedsmile:) the best easily available solvent for it is peg400 at around a 60%-80% mix with water (probably distilled or purified or whatever). Buying it from a mainstream source is genuinely expensive as fuck, on medchem express 100mg costs like 2k usd. Comparatively, from my source ky19382 costs around the same but for 10 grams, which lasts way way longer. To convert rat oral dosing to human dosing you have to determine human equivalent dose, which im not fucked explaining. Just ask ai to do it
sorry for the giga low effort thread i wasnt bothered finding pictures, if i got anything wrong please correct me cus this is all from memory

tagging high iq niggas
@Zagro @Stacyslayerᛉ @Sachlichkeit
[redacted] unironically upregulate hdac4 lol
 
Last edited:
  • +1
Reactions: birthdefect
ya

but WNTB pathway activation via KY19382 at human adjusted doses low reward high risk. At adjusted doses the cancer risk is massive correct me if im wrong.

Between theory and practical application you want to steer clear of research chemicals and lean on FDA approved drugs if you actually intend on using these things. I have bottle of oral self compounded KY in fridge rn, grew my hair out nice, thats about it. dosages were v and adjusted from anecdotal account of old poster who (apparently,) injected it. also muscle soreness.

ROMO is only FDA approved WNTB cantenin modulator, and has little effect on plates

TGFB transforming growth factor beta is more important for bone growth than WNTB though there is no drug available

if u want real edge on .org "competition" find out what the medical standard for X or Y is and then use that, because billions of dollars and hours have been poured into things you are probably researching.

I could say deca is the best steroid for bones, but some oldhead probably 30 years ago said the same thing, ran the studies, wasted bunch of time and money only to find out that testosterone is better risk reward for X or Y reason.

If "pfizer" could make a better androgen than testosterone, patent it, then market it as "TRT" they would because they would make billions, but they haven't.

The osteoporotic drugs are,
Romosozumab
PTH analogs
Biphosphonates
good points but ky19382 does not directly increase WNT in a sense it forces your body to produce more.
The pathways it works on, inhibiting CXXX5-dvl and GSK3-beta have a neutral effects on cancer proliferation, with less gsk3 actually lessening the risk short term
 
  • +1
Reactions: birthdefect
good points but ky19382 does not directly increase WNT in a sense it forces your body to produce more.
The pathways it works on, inhibiting CXXX5-dvl and GSK3-beta have a neutral effects on cancer proliferation, with less gsk3 actually lessening the risk short term
it simply depends on the type of cancer. in some gsk3 beta can act as a tumour promoter, and in others a suppressor
and iirc, ky doesnt just promote wnt uncontrollably, and in cSSC it can actually down regulate the cancerous growth factor involved
 
disclaimer: this is my thread from .gg
again just gonna be a quick thread like the last one on combining ghrfs + gh

ky19382 is a small molecule indirubin analogue which acts primarily as an inhibitor of the protein-protein interaction between CXXC5 and Dishevelled (dvl), while simultaneously acting as a Glycogen Synthase Kinase 3 Beta(gsk3b) inhibitor. Through these actions, it acts as a potent canonical Wnt/Beta catenin upregulator. Originally used to treat alopecia through upregulation of the Wnt/B catenin pathway, it was found to also promote wound healing, and most importantly longitudinal growth in adolescent mice.

Hair growth: ky19382 was shown to be more effective than minoxidil in rats in one study, and was able to promote de novo follicle formation, as in the growth of completely new hair follicles in adult tissue, thought to have been impossible until the discovery of this and other Wnt and HH modulators/upregulators.

Wound Healing: ky19382 accelerates wound healing by around 30%-50%, and was significantly faster than using endothelial growth factor (EGF) and PTD-DBM, which is a peptide that targets the same pathway as ky19382 itself. PTD-DBM is most likely inferior to ky19382 due to not affecting gsk3b, a factor which when inhibited, promotes the accumulation of nuclear beta catenin, which is beneficial for all of ky19382's desired effects.

Longitudinal growth:
This is the real important part on why ky19382 is such a mogger compound.
I'm sure that basically everyone on here knows that estrogen fuses the plates. It does this through both genomic and non genomic signalling pathways, which I'm not going to get deep into. When estrogen binds to the estrogen receptor alpha (ErA), it dimerises into hetero or homo dimers and moves within the nucleus of the cell. These dimers bind to estrogen response elements (ERE) in the cxxc5 promoter region of the dna, leading to increased cxxc5 expression which acts as the direct tool to upregulate growth plate fusion. CXXC5 causes a decrease in nuclear beta catenin levels, which are necessary to promote proliferative genes such as Sox9. We know a lack of CXXC5 can prevent estrogen from inducing senescence, because in mice models where the gene of CXXC5 is knocked out, the plates can't close even in high estrogen environments.

From this, I'm sure you've gathered that CXXC5 inhibition is very downstream and likely smarter compared to the relatively caveman-brained method of just inhibiting aromatase to slow bone age. But, does this mean its enough?

Is aromatase inhibition still needed?

From the studies with CXXC5 knockout models, we know that even if CXXC5 is missing and the plates cant fuse, estrogen genomic signalling still occurs as the receptor can bind to other genes. This means that even though your chondrocytes will keep proliferating and hypertrophying, your chondrocytes will still "age", in the sense that as they continue to multiply, they will retain the genomic changes made by estrogen, maturing and dying faster than they would have otherwise. Using ky19382 would likely allow for estrogen levels to be higher than actually needed to delay fusion, but you might still need to use low dose aromatase inhibitors (i recommend arimidex). I genuinely believe that aromatase inhibition combined with cxxc5 - dvl inhibition could potentially add 3+ years of active growth plate chondrocyte proliferation, hypertrophy, and thus growth.

Can more be done?

I'm sure most of you have heard of HDACi to promote longitudinal growth, unfortunately the reasoning behind it is pretty shit and pan-hdaci such as vorinostat are known to have a detrimental impact on growth. A lot of hdacs are necessary for longitudinal growth to occur, and one of high interest is HDAC4. HDAC4 is a crucial downstream factor to prevent chondrocytes from beginning to hypertrophy. Theoretically, if HDAC4 was upregulated, aromatase was inhibited, and cxxc5 - dvl interaction was inhibited, the growth plate may never fuse, allowing us to use androgens and hgh for pretty much as long as we need. I'm not going to get into how HDAC4 could be increased in the growth plate (likely gonna gatekeep further information on exact compounds needed), but the potential is there.

How would KY19382 actually be used?

A benefit of using small molecules over most other compounds is oral bioavailability, which ky19382 favourably exhibits. From some studies ive read (and just asking google's ai :forcedsmile:) the best easily available solvent for it is peg400 at around a 60%-80% mix with water (probably distilled or purified or whatever). Buying it from a mainstream source is genuinely expensive as fuck, on medchem express 100mg costs like 2k usd. Comparatively, from my source ky19382 costs around the same but for 10 grams, which lasts way way longer. To convert rat oral dosing to human dosing you have to determine human equivalent dose, which im not fucked explaining. Just ask ai to do it
sorry for the giga low effort thread i wasnt bothered finding pictures, if i got anything wrong please correct me cus this is all from memory

tagging high iq niggas
@Zagro @Stacyslayerᛉ @Sachlichkeit[/
[/QUOTE]
 
disclaimer: this is my thread from .gg
again just gonna be a quick thread like the last one on combining ghrfs + gh

ky19382 is a small molecule indirubin analogue which acts primarily as an inhibitor of the protein-protein interaction between CXXC5 and Dishevelled (dvl), while simultaneously acting as a Glycogen Synthase Kinase 3 Beta(gsk3b) inhibitor. Through these actions, it acts as a potent canonical Wnt/Beta catenin upregulator. Originally used to treat alopecia through upregulation of the Wnt/B catenin pathway, it was found to also promote wound healing, and most importantly longitudinal growth in adolescent mice.

Hair growth: ky19382 was shown to be more effective than minoxidil in rats in one study, and was able to promote de novo follicle formation, as in the growth of completely new hair follicles in adult tissue, thought to have been impossible until the discovery of this and other Wnt and HH modulators/upregulators.

Wound Healing: ky19382 accelerates wound healing by around 30%-50%, and was significantly faster than using endothelial growth factor (EGF) and PTD-DBM, which is a peptide that targets the same pathway as ky19382 itself. PTD-DBM is most likely inferior to ky19382 due to not affecting gsk3b, a factor which when inhibited, promotes the accumulation of nuclear beta catenin, which is beneficial for all of ky19382's desired effects.

Longitudinal growth:
This is the real important part on why ky19382 is such a mogger compound.
I'm sure that basically everyone on here knows that estrogen fuses the plates. It does this through both genomic and non genomic signalling pathways, which I'm not going to get deep into. When estrogen binds to the estrogen receptor alpha (ErA), it dimerises into hetero or homo dimers and moves within the nucleus of the cell. These dimers bind to estrogen response elements (ERE) in the cxxc5 promoter region of the dna, leading to increased cxxc5 expression which acts as the direct tool to upregulate growth plate fusion. CXXC5 causes a decrease in nuclear beta catenin levels, which are necessary to promote proliferative genes such as Sox9. We know a lack of CXXC5 can prevent estrogen from inducing senescence, because in mice models where the gene of CXXC5 is knocked out, the plates can't close even in high estrogen environments.

From this, I'm sure you've gathered that CXXC5 inhibition is very downstream and likely smarter compared to the relatively caveman-brained method of just inhibiting aromatase to slow bone age. But, does this mean its enough?

Is aromatase inhibition still needed?

From the studies with CXXC5 knockout models, we know that even if CXXC5 is missing and the plates cant fuse, estrogen genomic signalling still occurs as the receptor can bind to other genes. This means that even though your chondrocytes will keep proliferating and hypertrophying, your chondrocytes will still "age", in the sense that as they continue to multiply, they will retain the genomic changes made by estrogen, maturing and dying faster than they would have otherwise. Using ky19382 would likely allow for estrogen levels to be higher than actually needed to delay fusion, but you might still need to use low dose aromatase inhibitors (i recommend arimidex). I genuinely believe that aromatase inhibition combined with cxxc5 - dvl inhibition could potentially add 3+ years of active growth plate chondrocyte proliferation, hypertrophy, and thus growth.

Can more be done?

I'm sure most of you have heard of HDACi to promote longitudinal growth, unfortunately the reasoning behind it is pretty shit and pan-hdaci such as vorinostat are known to have a detrimental impact on growth. A lot of hdacs are necessary for longitudinal growth to occur, and one of high interest is HDAC4. HDAC4 is a crucial downstream factor to prevent chondrocytes from beginning to hypertrophy. Theoretically, if HDAC4 was upregulated, aromatase was inhibited, and cxxc5 - dvl interaction was inhibited, the growth plate may never fuse, allowing us to use androgens and hgh for pretty much as long as we need. I'm not going to get into how HDAC4 could be increased in the growth plate (likely gonna gatekeep further information on exact compounds needed), but the potential is there.

How would KY19382 actually be used?

A benefit of using small molecules over most other compounds is oral bioavailability, which ky19382 favourably exhibits. From some studies ive read (and just asking google's ai :forcedsmile:) the best easily available solvent for it is peg400 at around a 60%-80% mix with water (probably distilled or purified or whatever). Buying it from a mainstream source is genuinely expensive as fuck, on medchem express 100mg costs like 2k usd. Comparatively, from my source ky19382 costs around the same but for 10 grams, which lasts way way longer. To convert rat oral dosing to human dosing you have to determine human equivalent dose, which im not fucked explaining. Just ask ai to do it
sorry for the giga low effort thread i wasnt bothered finding pictures, if i got anything wrong please correct me cus this is all from memory

tagging high iq niggas
@Zagro @Stacyslayerᛉ @Sachlichkeit[/
[QUOTE="birthdefect, post: 25579319, member: 301234"]
disclaimer: this is my thread from .gg
again just gonna be a quick thread like the last one on combining ghrfs + gh
[URL unfurl="true"]https://looksmax.org/threads/combination-of-ghrfs-and-gh-high-iq-negros-gtfih.1813264/[/URL]

ky19382 is a small molecule indirubin analogue which acts primarily as an inhibitor of the protein-protein interaction between CXXC5 and Dishevelled (dvl), while simultaneously acting as a Glycogen Synthase Kinase 3 Beta(gsk3b) inhibitor. Through these actions, it acts as a potent canonical Wnt/Beta catenin upregulator. Originally used to treat alopecia through upregulation of the Wnt/B catenin pathway, it was found to also promote wound healing, and most importantly longitudinal growth in adolescent mice.

Hair growth: ky19382 was shown to be more effective than minoxidil in rats in one study, and was able to promote de novo follicle formation, as in the growth of completely new hair follicles in adult tissue, thought to have been impossible until the discovery of this and other Wnt and HH modulators/upregulators.

Wound Healing: ky19382 accelerates wound healing by around 30%-50%, and was significantly faster than using endothelial growth factor (EGF) and PTD-DBM, which is a peptide that targets the same pathway as ky19382 itself. PTD-DBM is most likely inferior to ky19382 due to not affecting gsk3b, a factor which when inhibited, promotes the accumulation of nuclear beta catenin, which is beneficial for all of ky19382's desired effects.

Longitudinal growth:
This is the real important part on why ky19382 is such a mogger compound.
I'm sure that basically everyone on here knows that estrogen fuses the plates. It does this through both genomic and non genomic signalling pathways, which I'm not going to get deep into. When estrogen binds to the estrogen receptor alpha (ErA), it dimerises into hetero or homo dimers and moves within the nucleus of the cell. These dimers bind to estrogen response elements (ERE) in the cxxc5 promoter region of the dna, leading to increased cxxc5 expression which acts as the direct tool to upregulate growth plate fusion. CXXC5 causes a decrease in nuclear beta catenin levels, which are necessary to promote proliferative genes such as Sox9. We know a lack of CXXC5 can prevent estrogen from inducing senescence, because in mice models where the gene of CXXC5 is knocked out, the plates can't close even in high estrogen environments.

From this, I'm sure you've gathered that CXXC5 inhibition is very downstream and likely smarter compared to the relatively caveman-brained method of just inhibiting aromatase to slow bone age. But, does this mean its enough?

[B][I]Is aromatase inhibition still needed?[/I][/B]

From the studies with CXXC5 knockout models, we know that even if CXXC5 is missing and the plates cant fuse, estrogen genomic signalling still occurs as the receptor can bind to other genes. This means that even though your chondrocytes will keep proliferating and hypertrophying, your chondrocytes will still "age", in the sense that as they continue to multiply, they will retain the genomic changes made by estrogen, maturing and dying faster than they would have otherwise. Using ky19382 would likely allow for estrogen levels to be higher than actually needed to delay fusion, but you might still need to use low dose aromatase inhibitors (i recommend arimidex). I genuinely believe that aromatase inhibition combined with cxxc5 - dvl inhibition could potentially add 3+ years of active growth plate chondrocyte proliferation, hypertrophy, and thus growth.

[B][I]Can more be done?[/I][/B]

I'm sure most of you have heard of HDACi to promote longitudinal growth, unfortunately the reasoning behind it is pretty shit and pan-hdaci such as vorinostat are known to have a detrimental impact on growth. A lot of hdacs are necessary for longitudinal growth to occur, and one of high interest is HDAC4. HDAC4 is a crucial downstream factor to prevent chondrocytes from beginning to hypertrophy. Theoretically, if HDAC4 was upregulated, aromatase was inhibited, and cxxc5 - dvl interaction was inhibited, the growth plate may [I][B]never [/B][/I]fuse, allowing us to use androgens and hgh for pretty much as long as we need. I'm not going to get into how HDAC4 could be increased in the growth plate (likely gonna gatekeep further information on exact compounds needed), but the potential is there.

[B][I]How would KY19382 actually be used?[/I][/B]

A benefit of using small molecules over most other compounds is oral bioavailability, which ky19382 favourably exhibits. From some studies ive read (and just asking google's ai :forcedsmile:) the best easily available solvent for it is peg400 at around a 60%-80% mix with water (probably distilled or purified or whatever). Buying it from a mainstream source is genuinely expensive as fuck, on medchem express 100mg costs like 2k usd. Comparatively, from my source ky19382 costs around the same but for 10 grams, which lasts way way longer. To convert rat oral dosing to human dosing you have to determine human equivalent dose, which im not fucked explaining. Just ask ai to do it
[SIZE=9px]sorry for the giga low effort thread i wasnt bothered finding pictures, if i got anything wrong please correct me cus this is all from memory[/SIZE]

tagging high iq niggas
[USER=88665]@Zagro
@Stacyslayerᛉ @Sachlichkeit
to actually dilute the powder yourself you need dsmo as well and peg 400 and it’s pretty complex to do yourself you need actua equipment a good dose for a human is around 2mg a day
[/QUOTE]
 
I would need like 60mg daily for the translated human dose + considering the bioavailability changes in oral dosing, so even buying 1g for 200$ it lasts like 15 days
Inject it
 
to actually dilute the powder yourself you need dsmo as well and peg 400 and it’s pretty complex to do yourself you need actua equipment a good dose for a human is around 2mg a day
light work to dissolve it yourself, the solvents arent that expensive
you can even make a mixed micellar system or a snedds
Need to inject it buddy no point otherwise
for what reason, it being a small molecule is the biggest reason to take it orally or sublingually
and im not injecting something i brewed up at home tbh
 
I would need like 60mg daily for the translated human dose + considering the bioavailability changes in oral dosing, so even buying 1g for 200$ it lasts like 15 days
66kg and you need to also consider that the oral bioavailability is like 10%-25% max
Where did you get this numbers from? :kys:
 
light work to dissolve it yourself, the solvents arent that expensive
you can even make a mixed micellar system or a snedds

for what reason, it being a small molecule is the biggest reason to take it orally or sublingually
and im not injecting something i brewed up at home tbh
injectable seems to perform worse than oral
 
  • Woah
Reactions: birthdefect
disclaimer: this is my thread from .gg
again just gonna be a quick thread like the last one on combining ghrfs + gh

ky19382 is a small molecule indirubin analogue which acts primarily as an inhibitor of the protein-protein interaction between CXXC5 and Dishevelled (dvl), while simultaneously acting as a Glycogen Synthase Kinase 3 Beta(gsk3b) inhibitor. Through these actions, it acts as a potent canonical Wnt/Beta catenin upregulator. Originally used to treat alopecia through upregulation of the Wnt/B catenin pathway, it was found to also promote wound healing, and most importantly longitudinal growth in adolescent mice.

Hair growth: ky19382 was shown to be more effective than minoxidil in rats in one study, and was able to promote de novo follicle formation, as in the growth of completely new hair follicles in adult tissue, thought to have been impossible until the discovery of this and other Wnt and HH modulators/upregulators.

Wound Healing: ky19382 accelerates wound healing by around 30%-50%, and was significantly faster than using endothelial growth factor (EGF) and PTD-DBM, which is a peptide that targets the same pathway as ky19382 itself. PTD-DBM is most likely inferior to ky19382 due to not affecting gsk3b, a factor which when inhibited, promotes the accumulation of nuclear beta catenin, which is beneficial for all of ky19382's desired effects.

Longitudinal growth:
This is the real important part on why ky19382 is such a mogger compound.
I'm sure that basically everyone on here knows that estrogen fuses the plates. It does this through both genomic and non genomic signalling pathways, which I'm not going to get deep into. When estrogen binds to the estrogen receptor alpha (ErA), it dimerises into hetero or homo dimers and moves within the nucleus of the cell. These dimers bind to estrogen response elements (ERE) in the cxxc5 promoter region of the dna, leading to increased cxxc5 expression which acts as the direct tool to upregulate growth plate fusion. CXXC5 causes a decrease in nuclear beta catenin levels, which are necessary to promote proliferative genes such as Sox9. We know a lack of CXXC5 can prevent estrogen from inducing senescence, because in mice models where the gene of CXXC5 is knocked out, the plates can't close even in high estrogen environments.

From this, I'm sure you've gathered that CXXC5 inhibition is very downstream and likely smarter compared to the relatively caveman-brained method of just inhibiting aromatase to slow bone age. But, does this mean its enough?

Is aromatase inhibition still needed?

From the studies with CXXC5 knockout models, we know that even if CXXC5 is missing and the plates cant fuse, estrogen genomic signalling still occurs as the receptor can bind to other genes. This means that even though your chondrocytes will keep proliferating and hypertrophying, your chondrocytes will still "age", in the sense that as they continue to multiply, they will retain the genomic changes made by estrogen, maturing and dying faster than they would have otherwise. Using ky19382 would likely allow for estrogen levels to be higher than actually needed to delay fusion, but you might still need to use low dose aromatase inhibitors (i recommend arimidex). I genuinely believe that aromatase inhibition combined with cxxc5 - dvl inhibition could potentially add 3+ years of active growth plate chondrocyte proliferation, hypertrophy, and thus growth.

Can more be done?

I'm sure most of you have heard of HDACi to promote longitudinal growth, unfortunately the reasoning behind it is pretty shit and pan-hdaci such as vorinostat are known to have a detrimental impact on growth. A lot of hdacs are necessary for longitudinal growth to occur, and one of high interest is HDAC4. HDAC4 is a crucial downstream factor to prevent chondrocytes from beginning to hypertrophy. Theoretically, if HDAC4 was upregulated, aromatase was inhibited, and cxxc5 - dvl interaction was inhibited, the growth plate may never fuse, allowing us to use androgens and hgh for pretty much as long as we need. I'm not going to get into how HDAC4 could be increased in the growth plate (likely gonna gatekeep further information on exact compounds needed), but the potential is there.

How would KY19382 actually be used?

A benefit of using small molecules over most other compounds is oral bioavailability, which ky19382 favourably exhibits. From some studies ive read (and just asking google's ai :forcedsmile:) the best easily available solvent for it is peg400 at around a 60%-80% mix with water (probably distilled or purified or whatever). Buying it from a mainstream source is genuinely expensive as fuck, on medchem express 100mg costs like 2k usd. Comparatively, from my source ky19382 costs around the same but for 10 grams, which lasts way way longer. To convert rat oral dosing to human dosing you have to determine human equivalent dose, which im not fucked explaining. Just ask ai to do it
sorry for the giga low effort thread i wasnt bothered finding pictures, if i got anything wrong please correct me cus this is all from memory

tagging high iq niggas
@Zagro @Stacyslayerᛉ @Sachlichkeit
nice to come back and see something actually well constructed posted here for once, been a while. will come back tomorrow with a detailed reply when im not half asleep, but already clocking some potential issues in the logic presented that i think are worth addressing. the HDAC4 debunk in particular feels like it may be working off a somewhat incomplete picture of the timing and selectivity of its role in the hypertrophic zone specifically that may translate questionably in human subjects, hold that thought tho I gotta sleep
 
  • +1
Reactions: birthdefect
nice to come back and see something actually well constructed posted here for once, been a while. will come back tomorrow with a detailed reply when im not half asleep, but already clocking some potential issues in the logic presented that i think are worth addressing. the HDAC4 debunk in particular feels like it may be working off a somewhat incomplete picture of the timing and selectivity of its role in the hypertrophic zone specifically that may translate questionably in human subjects, hold that thought tho I gotta sleep
will wait
about hdac4, it is necessary to prevent hypertrophy as you already read, similar to pth/pthrp analogues
its actually a downstream factor that prevents hypertrophy
preventing hypertrophy is a double edged sword inherently, you need it for growth but too much will stunt you hard
 
yeah but its so fucking expensive and hard to source
my source cost like 750 for 3g
human equivalent dose is very small, far from the 60mg daily he mentioned
0.08108108108mg/kg of bodyweight
 
my source cost like 750 for 3g
human equivalent dose is very small, far from the 60mg daily he mentioned
0.08108108108mg/kg of bodyweight
oh shit ill think abt it then can u send it in pms if u want u dont have to:feelsshh:
 
oh shit ill think abt it then can u send it in pms if u want u dont have to:feelsshh:
i will later, ive already posted it publicly on gg if you have an account there
 

Similar threads

M
Replies
20
Views
359
infrainfra
infrainfra
topology
Replies
44
Views
307
Swarthy Knight
Swarthy Knight
J
Replies
33
Views
949
jalooks
J
viper__7
Replies
29
Views
2K
viper__7
viper__7
nicheroider
Replies
36
Views
2K
pedro218
pedro218

Users who are viewing this thread

Back
Top